World

Germany's Scholz says now is time to plan for future of Gaza Strip

Jan 29, 2025

Berlin [Germany], January 29: German Chancellor Olaf Scholz on Tuesday urged greater progress in shaping the political and economic future of the Gaza Strip, following the release of further hostages by the Palestinian group Hamas.
"It is now important that the ceasefire holds and that all hostages are released. And that the inhabitants of the Gaza Strip are reliably and comprehensively supplied with humanitarian and medical aid," Scholz said at a joint press conference in Berlin with visiting Danish Prime Minister Mette Frederiksen.
Scholz said the German government is pleased that Israeli hostages have again been released from the hands of Hamas, which he described as a terrorist group following its unprecedented attack on Israel on October 7, 2023.
The German chancellor emphasized that Palestinians living in Gaza need to be given prospects for lives of freedom and dignity in order to avoid the territory becoming a "breeding ground for extremism and hatred." "Germany, the EU, are prepared to play their part in this if the framework conditions are right," Scholz said.
He called for a reformed Palestinian Authority to take responsibility for administering Gaza, which has been extensively destroyed during Israel's campaign of airstrikes and military ground offensives.
After more than a year of war, a ceasefire between Israel and Hamas came into force two weeks ago.
During the initial six-week phase, 33 Israeli hostages held by Hamas are to be exchanged for 1,904 Palestinian prisoners from Israeli jails.
Seven of the 33 hostages have already been released. A total of 90 hostages are still being held in the Gaza Strip, most of whom were abducted during the Hamas-led attacks on Israel in 2023.
According to Israeli reports, 35 of the remaining hostages are dead.
Source: Qatar Tribune

More news

Sirolimus-Coated Balloon Matches Drug-Eluting Stent at One Year in Large International TRANSFORM II Trial

Tampa (Florida) [US], November 2: Sirolimus-coated balloon (SCB) strategy was non-inferior to contemporary everolimus-eluting stents (EES) for Target Lesion Failure (TLF) at 12 months in patients with de novo coronary artery disease. These are the results of the TRANSFORM II randomised trial, presented today as a Late-Breaking Clinical Trial at TCT 2026 and accepted in The Lancet which confirm how MagicTouch Sirolimus Coated Balloon (Concept Medical) matches contemporary best in class stent. Late-breaking results presented at TCT 2026 show an implant-free strategy with MagicTouch Sirolimus Coated Balloon is non-inferior to everolimus-eluting in de novo coronary artery disease.

Nov 02, 2026